Shareholders of Gemabank (MOEX: GEMA), by means of absentee voting, have resolved to pay out dividends in the amount of RUB 3 per ordinary share. The record date for determining the persons entitled to receive dividends has been set for December 30, 2025.
Gemabank is part of the Artgen Biotech Group (MOEX: ABIO). Gemabank is a biotechnology company specializing in the private blood stem cells banking and the development of gene therapy treatments for blood and immune system disorders.